Lixte Biotechnology Holdings Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell

24

LIXT
Lixte Biotechnology Holdings

Last Price:

1.69

Seasonality Move:

-4.66%

Sell

28

NBY
NovaBay Pharmaceuticals

Last Price:

0.69

Seasonality Move:

1.46%

Sell

24

Lixte Biotechnology Holdings (LIXT) is a Sell

Is Lixte Biotechnology Holdings a Buy, Sell or Hold?

The current Lixte Biotechnology Holdings [LIXT] share price is $1.63. The Score for LIXT is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
LIXT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

28

NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

The current NovaBay Pharmaceuticals [NBY] share price is $0.68. The Score for NBY is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LIXT Stock Price Chart

What is Lixte Biotechnology Holdings's stock price today?

The Lixte Biotechnology Holdings share price today is $1.63
The current trend is relatively stagnant and LIXT is experiencing slight selling pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

The NovaBay Pharmaceuticals share price today is $0.68
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing selling pressure, which indicates risk of future bearish movement.

LIXT Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.08	Sell
Relative Strength Index (14 RSI):	46.07	Sell
Chaikin Money Flow:	-12658	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(1.53 - 1.97)	Sell
Bollinger Bands (100):	(1.71 - 2.21)	Sell

NBY Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.01	Buy
Relative Strength Index (14 RSI):	48.48	Sell
Chaikin Money Flow:	-30586	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(0.61 - 0.75)	Buy
Bollinger Bands (100):	(0.28 - 1.42)	Sell

LIXT Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	1.58	Buy
20-day SMA:	1.73	Sell
50-day SMA:	1.81	Sell
200-day SMA:	2.32	Sell
8-day EMA:	1.59	Buy
20-day EMA:	1.68	Sell
50-day EMA:	1.8	Sell
200-day EMA:	2.31	Sell

NBY Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	0.71	Sell
20-day SMA:	0.71	Sell
50-day SMA:	0.66	Buy
200-day SMA:	2.33	Sell
8-day EMA:	0.71	Sell
20-day EMA:	0.7	Sell
50-day EMA:	0.73	Sell
200-day EMA:	5.57	Sell

Lixte Biotechnology Holdings Earnings Growth & LIXT Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Lixte Biotechnology Holdings Technical Analysis

	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15	Nov 18	Nov 19	Nov 20	Nov 21	Nov 22
	Nov
	11	12	13	14	15	18	19	20	21	22
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15	Nov 18	Nov 19	Nov 20	Nov 21	Nov 22
	Nov
	11	12	13	14	15	18	19	20	21	22
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):